Roger Meier

Roger Meier has worked in various roles in the biopharmaceutical industry since 1998. Roger was the founder and owner of Clarena AG in 1998, and a board member and co-founder of STREKIN AG in 2014. Roger was a co-founder of Cellestia Biotech in 2015 and T3 Pharmaceuticals AG in 2016, as well as a board member of Aurealis Pharma in 2016. In 2017, they were a co-founder and former board member of Kinarus AG, and a co-founder and former chairman/delegate of the board of Versameb AG. Since 2018, they have been the chairman of the board and co-founder of Aurealis Therapeutics, Acthera Therapeutics Ltd., and NEMIS Technologies AG.

Roger Meier attended the University of Applied Sciences Basel.